Ritonavir

ATP-binding cassette, subfamily B (MDR/TAP), member 1B ; Rattus norvegicus







10 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 23883365 Enhanced oral bioavailability of felodipine by naringenin in Wistar rats and inhibition of P-glycoprotein in everted rat gut sacs in vitro. 2014 Oct 2
2 23589366 Time-dependent interaction of ritonavir in chronic use: the power balance between inhibition and induction of P-glycoprotein and cytochrome P450 3A. 2013 Jun 7
3 18520056 Long-term pharmacokinetic efficacy and safety of low-dose ritonavir as a booster and atazanavir pharmaceutical formulation based on solid dispersion system in rats. 2008 Jun 6
4 17409512 Pharmaceutical approach to HIV protease inhibitor atazanavir for bioavailability enhancement based on solid dispersion system. 2007 Apr 4
5 16545584 Development and characterization of LLC-PK1 cells containing Sprague-Dawley rat Abcb1a (Mdr1a): comparison of rat P-glycoprotein transport to human and mouse. 2006 Jul-Aug 1
6 15635177 Effect of chronic administration of ritonavir on function of cytochrome P450 3A and P-glycoprotein in rats. 2005 Jan 9
7 14985144 Ritonavir and dexamethasone induce expression of CYP3A and P-glycoprotein in rats. 2004 Feb 3
8 12604693 Pharmacokinetics and interactions of a novel antagonist of chemokine receptor 5 (CCR5) with ritonavir in rats and monkeys: role of CYP3A and P-glycoprotein. 2003 Mar 3
9 12112443 Functional expression and localization of P-glycoprotein at the blood brain barrier. 2002 Jun 1 1
10 11093774 Xenobiotic transport across isolated brain microvessels studied by confocal microscopy. 2000 Dec 1